ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents to support the development of target therapeutics and diagnostic kits. The company employs an application oriented development strategy, with a particular focus on product design, quality control and solution based support. Our products and services enable anyone in the field of drug development to have a more intuitive and streamlined process.
We have developed an extensive collection of recombinant proteins to support CAR-T therapy development. This growing list of proteins includes many fluorescent-labeled target antigens and pre-biotinylated proteins that are uniquely suitable for evaluation of CAR expression, such as BCMA, CD19, ROR1, and EGFRVIII. In addition, ACROBiosystems has submitted DMF for its recombinant CD19 and BCMA proteins to FDA, and filed the DMF number as 034936.